TCL Archive Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy November 25, 2011
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
